The content on this site is intended for healthcare professionals only
Clinical Requirements Regarding In Silico Oncology
Published: 23 Jan 2009
Views: 11460
Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland
Lecture from the European Union ICT BIO 2008 Conference (Oct. 23-24, 2008) on Clinical Requirements Regarding In Silico Oncology
- Categories:
- Haematology oncology
Related Videos
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
22 Nov 2021
Paediatric ALL perspective
Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
12 Nov 2021
Optimal use of asparaginase for acute lymphoblastic leukaemia
Dr Ibrahim Aldoss - City of Hope, Duarte, USA
10 Nov 2021
Mobile supportive care for children and young adults with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
10 Nov 2021
Post-HSCT management of paediatric patients with ALL
Prof Christina Peters - St. Anna Children's Hospital, Vienna Austria
10 Nov 2021
Workshop diagnostics procedures in ALL
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
10 Nov 2021
Practical applications on new data of genetic ALL subtypes
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
10 Nov 2021
Triple class refractory multiple myeloma
Prof Joseph Mikhael - Translational Genomics Research Institute (TGen), Phoenix,...
10 Nov 2021
Managing high-risk/MRD positive and standard-risk/MRD myeloma
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
29 Oct 2021
